MEDIROM Healthcare Technologies (MRM) Stock Price, News & Analysis

Company Overview

MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, an on-demand health monitoring smartphone application and MOTHER Bracelet for fitness applications; and preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

Key Stats

• Today's Range: $0.58 to $0.65
• 50-Day Range: $0.66 to $1.12
• 52-Week Range: $0.60 to $8.39
• Volume: 17,531 shs
• Average Volume: 226,710 shs
• Market Capitalization: $3.09 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Strong Buy

MRM Stock Analysis - Frequently Asked Questions

How have MRM shares performed this year?

MEDIROM Healthcare Technologies' stock was trading at $1.03 at the start of the year. Since then, MRM shares have decreased by 37.4% and is now trading at $0.6450.
View the best growth stocks for 2025 here.

When did MEDIROM Healthcare Technologies IPO?

MEDIROM Healthcare Technologies (MRM) raised $12 million in an IPO on Tuesday, December 29th 2020. The company issued 800,000 shares at a price of $15.00 per share. Maxim Group LLC acted as the underwriter for the IPO.

Who are MEDIROM Healthcare Technologies' major shareholders?

Top institutional investors of MEDIROM Healthcare Technologies include Heights Capital Management Inc. (0.72%).

How do I buy shares of MEDIROM Healthcare Technologies?

Shares of MRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of MEDIROM Healthcare Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MEDIROM Healthcare Technologies investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), AppLovin (APP), e.l.f. Beauty (ELF) and Disc Medicine (IRON).

Company Calendar

• Today: 3/10/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Personal services
• Sub-Industry: Personal Services
• Current Symbol: NYSE:MRM
• CIK: 1819704
• Web: medirom.co.jp
• Phone: 813-6721-7364
• Fax: N/A
• Employees: 1,101
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.34
• Quick Ratio: 0.29

Sales & Book Value

• Annual Sales: $7.15 billion
• Price / Sales: 0.00
• Cash Flow: $0.45 per share
• Price / Cash Flow: 1.49
• Book Value: $0.31 per share
• Price / Book: 2.16

Miscellaneous

• Outstanding Shares: 4,938,000
• Free Float: 2,951,000
• Market Cap: $3.31 million
• Optionable: Not Optionable
• Beta: 0.39